Physician
Covenant Medical Group
Covenant Medical Group was paid $34.48M by Medicaid between Jan 2018 and Dec 2024, across 208 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.
33Billing provider infoCOVENANT MEDICAL GROUP
LUBBOCK, TX 79410
LUBBOCK, TX 79410
33aNPI1376598904assigned 05/23/2006
33bProvider typeSurgery Physician
28Total paid$34.48M
24GClaims880,544
24DCodes billed208
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Surgery Physician providers in Texas
Rank by total paid#1 of 98
Median peer was paid$8K
This provider vs. median4,117×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 11,396 | $313K | |
| 2019 | 11,824 | $359K | |
| 2020 | 33,347 | $1.16M | |
| 2021 | 188,933 | $7.68M | |
| 2022 | 209,649 | $8.26M | |
| 2023 | 263,234 | $10.24M | |
| 2024incomplete | 162,161 | $6.46M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 143,981 | 129,249 | $7.12M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 91,524 | 85,220 | $5.89M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 4.8% | 12,218 | 10,699 | $1.67M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 4.7% | 37,258 | 35,954 | $1.62M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.2% | 19,927 | 19,135 | $1.45M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.8% | 47,869 | 45,667 | $1.30M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.7% | 28,033 | 26,586 | $1.27M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 3.4% | 17,993 | 17,312 | $1.17M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.4% | 15,884 | 15,592 | $1.16M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.2% | 16,308 | 15,176 | $1.11M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.6% | 13,203 | 12,514 | $898K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 2.5% | 6,108 | 5,962 | $857K |
196 more codes
| 99203 | Doctor's office visit, new patient (routine) | 2.0% | 8,830 | $698K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.8% | 8,150 | $613K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.5% | 6,937 | $526K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 1.5% | 2,295 | $513K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.4% | 75,905 | $481K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.2% | 3,569 | $411K |
| 93320 | 1.2% | 12,084 | $401K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 3,549 | $338K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 4,887 | $300K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 2,548 | $295K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,973 | $234K |
| 76818 | <1% | 2,666 | $225K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 839 | $216K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 3,687 | $191K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 7,676 | $184K |
| 76801 | <1% | 2,042 | $177K | |
| 93325 | <1% | 12,397 | $173K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,942 | $170K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 13,265 | $161K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,674 | $159K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 679 | $138K |
| 87634 | <1% | 2,471 | $138K | |
| 93000 | <1% | 14,229 | $129K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 4,447 | $129K |
| 99460 | <1% | 1,923 | $126K | |
| 95813 | <1% | 1,611 | $111K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 8,401 | $106K |
| 90461 | <1% | 22,559 | $102K | |
| 95117 | <1% | 10,520 | $91K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 1,906 | $75K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 659 | $69K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 916 | $66K |
| 76825 | <1% | 313 | $57K | |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | <1% | 82 | $49K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,972 | $42K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 585 | $40K |
| 87631 | <1% | 349 | $39K | |
| 59430 | <1% | 405 | $36K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 676 | $34K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 415 | $32K |
| 94375 | <1% | 1,269 | $31K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,372 | $30K |
| 20610 | <1% | 1,088 | $30K | |
| 87581 | <1% | 1,063 | $30K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 219 | $29K |
| 80050 | General health panel | <1% | 895 | $28K |
| 59514 | <1% | 74 | $28K | |
| 90715 | <1% | 1,104 | $28K | |
| 99443 | <1% | 311 | $27K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 1,689 | $26K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,754 | $25K |
| 99221 | <1% | 414 | $24K | |
| 54150 | <1% | 384 | $24K | |
| 99243 | <1% | 222 | $21K | |
| 59025 | Fetal non-stress test | <1% | 779 | $21K |
| 99205 | Prolong outpt/office vis | <1% | 119 | $20K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 4,021 | $18K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,186 | $18K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 5,002 | $17K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 573 | $17K |
| 99223 | Prolong inpt eval add15 m | <1% | 277 | $17K |
| 99462 | <1% | 542 | $16K | |
| 99381 | <1% | 223 | $16K | |
| 76827 | <1% | 275 | $16K | |
| 80061 | Lipid panel | <1% | 1,911 | $15K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,752 | $14K |
| 99383 | <1% | 174 | $14K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 832 | $14K |
| 80053 | Comprehensive metabolic panel | <1% | 2,938 | $13K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 233 | $13K |
| 76820 | <1% | 314 | $11K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 268 | $11K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 187 | $11K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 93 | $11K |
| 87486 | <1% | 347 | $9K | |
| 81003 | <1% | 4,899 | $8K | |
| 73100 | <1% | 310 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 577 | $8K |
| 84439 | <1% | 1,957 | $8K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 59 | $8K |
| 87807 | <1% | 749 | $8K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 15 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 589 | $7K |
| 81001 | <1% | 3,221 | $7K | |
| 90686 | <1% | 8,685 | $7K | |
| 99385 | <1% | 47 | $7K | |
| 73080 | <1% | 240 | $6K | |
| 81025 | <1% | 723 | $6K | |
| 95816 | <1% | 170 | $5K | |
| 95024 | <1% | 85 | $5K | |
| 90677 | <1% | 3,945 | $5K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 53 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 953 | $5K |
| 93015 | <1% | 114 | $5K | |
| 99442 | <1% | 52 | $4K | |
| 99382 | <1% | 40 | $4K | |
| 82607 | <1% | 453 | $4K | |
| 25600 | <1% | 13 | $4K | |
| 73110 | <1% | 125 | $4K | |
| 90651 | <1% | 446 | $3K | |
| 74018 | <1% | 154 | $3K | |
| 90961 | <1% | 249 | $3K | |
| 92552 | <1% | 170 | $3K | |
| 94010 | <1% | 235 | $2K | |
| 99219 | <1% | 25 | $2K | |
| 99217 | <1% | 37 | $2K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 40 | $2K |
| 73610 | <1% | 81 | $2K | |
| 99220 | <1% | 15 | $2K | |
| 99152 | <1% | 147 | $2K | |
| 93458 | <1% | 12 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 500 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 503 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 115 | $2K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 182 | $2K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 14 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,701 | $1K |
| 96160 | <1% | 660 | $1K | |
| 72170 | <1% | 53 | $1K | |
| 77073 | <1% | 41 | $1K | |
| 90670 | <1% | 9,816 | $1K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 14 | $1K |
| 76813 | <1% | 12 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 13 | $1K |
| 81002 | <1% | 419 | $1K | |
| 93244 | <1% | 55 | $1K | |
| 82570 | <1% | 314 | $992.47 | |
| 96161 | <1% | 2,070 | $908.22 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 137 | $802.84 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 4,359 | $771.52 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 166 | $698.51 |
| 90682 | <1% | 45 | $674.00 | |
| 96380 | <1% | 139 | $673.18 | |
| 73590 | <1% | 27 | $637.19 | |
| 88720 | <1% | 175 | $611.11 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 13 | $606.07 |
| 93296 | <1% | 51 | $597.86 | |
| 99241 | <1% | 13 | $499.71 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 133 | $409.76 |
| 90680 | <1% | 4,608 | $337.53 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 217 | $322.17 |
| 73140 | <1% | 12 | $312.88 | |
| 82274 | <1% | 26 | $275.35 | |
| 93227 | <1% | 13 | $268.50 | |
| 90620 | <1% | 60 | $238.17 | |
| 93018 | <1% | 26 | $185.82 | |
| 90962 | <1% | 27 | $159.75 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 116 | $136.81 |
| 90656 | <1% | 1,251 | $106.80 | |
| 93016 | <1% | 12 | $88.40 | |
| 90723 | <1% | 6,893 | $76.03 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 27 | $69.12 |
| 85014 | <1% | 35 | $69.06 | |
| 85018 | <1% | 35 | $69.06 | |
| 90647 | <1% | 6,181 | $62.32 | |
| 92551 | <1% | 14 | $57.72 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | <1% | 14 | $57.32 |
| 85652 | <1% | 25 | $56.40 | |
| 86308 | <1% | 12 | $54.18 | |
| 82043 | <1% | 13 | $37.54 | |
| 96127 | <1% | 201 | $26.02 | |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | <1% | 43 | $23.83 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 15 | $23.54 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 148 | $15.46 |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 72 | $10.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 13 | $6.24 |
| 90633 | <1% | 3,319 | $0.04 | |
| 90381 | <1% | 30 | $0.04 | |
| 90648 | <1% | 990 | $0.03 | |
| 90710 | <1% | 761 | $0.02 | |
| 90681 | <1% | 1,206 | $0.02 | |
| 90380 | <1% | 12 | $0.01 | |
| 3078F | 0% | 16,604 | $0.00 | |
| 90700 | 0% | 236 | $0.00 | |
| 99173 | 0% | 242 | $0.00 | |
| 90707 | 0% | 166 | $0.00 | |
| 90734 | 0% | 175 | $0.00 | |
| 3077F | 0% | 40 | $0.00 | |
| 90662 | 0% | 14 | $0.00 | |
| 90621 | 0% | 13 | $0.00 | |
| 1036F | 0% | 5,452 | $0.00 | |
| 3074F | 0% | 19,499 | $0.00 | |
| 90697 | 0% | 1,377 | $0.00 | |
| 3079F | 0% | 3,647 | $0.00 | |
| 90688 | 0% | 32 | $0.00 | |
| 3075F | 0% | 945 | $0.00 | |
| H0049 | Alcohol and/or drug screening | 0% | 344 | $0.00 |
| 90716 | 0% | 179 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 108 | $0.00 |
| 90619 | 0% | 79 | $0.00 | |
| 90698 | 0% | 109 | $0.00 | |
| 3080F | 0% | 27 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 53 | $0.00 |
| 90696 | 0% | 77 | $0.00 | |
| 99429 | 0% | 12 | $0.00 | |
| 86580 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKOTHMANN, KRISTEN (COO)
| Provider | Location | Paid |
|---|---|---|
| Covenant Medical Group | Abernathy, TX | $23K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.